Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 141 - 150 of 200 for wx. (0.06 seconds)

WuXi AppTec reported it has been given a certificate of...
China’s central government spent $38.4 billion on...
AstraZeneca will spend $200 million to build a major new...
WuXi PharmaTech, a leading China CRO, has acquired...
WuXi PharmaTech will acquire two related China...
BioBay, the Suzhou life science park, formed a cancer...
WuXi PharmaTech has formed a $50 million corporate...
China National Biotechnology Group (CNBG) will raise as...
WuXi PharmaTech and ShangPharma are both attractive M&A...
WuXi PharmaTech and ShangPharma are both attractive M&A...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here